Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
6%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
ARKG
35
HOLDINGS
22%
ALSO IN IDNA
IDNA
44
HOLDINGS
18%
ALSO IN ARKG
SECTOR DRIFT (ARKG minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
| TWIST BIOSCIENCE CORP. | 5.1% | 2.9% | 2.9% | |
| INCYTE CORP | 1.3% | 5.1% | 1.3% | |
| PACIFIC BIOSCIENCES OF CALIF | 1.6% | 0.8% | 0.8% | |
| ALCOBRA LTD | 1.6% | 0.3% | 0.3% | |
| CRISPR THERAPEUTICS AG | 8.8% | 0.3% | 0.3% | |
ARKG Overweight Relative to IDNA
| CRISPR THERAPEUTICS AG | 8.5% | |
| GUARDANT HEALTH, INC. | 5.9% | |
| PERSONALIS, INC. | 5.3% | |
| 10X GENOMICS INC CLASS A | 4.7% | |
| NATERA INC | 4.6% | |
| RECURSION PHARMACEUTICALS, INC CLASS | 4.3% | |
| ILLUMINA INC | 4.2% | |
| BEAM THERAPEUTICS, INC. | 4.1% | |
| VERACYTE INC | 3.9% | |
| ADAPTIVE BIOTECHNOLOGIES CORP. | 3.3% |
ARKG Underweight Relative to IDNA
| REVOLUTION MEDICINES, INC. | -5.6% | |
| CELCUITY INC. | -5.5% | |
| REGENERON PHARMACEUTICALS | -4.8% | |
| GENMAB A/S | -4.7% | |
| ARCELLX, INC. | -4.5% | |
| ASTRAZENECA PLC | -4.2% | |
| MERCK & CO. INC. | -4.0% | |
| GSK PLC | -3.9% | |
| INCYTE CORP | -3.9% | |
| ROCHE HOLDING LTD | -3.8% |